Nothing Special   »   [go: up one dir, main page]

Kamens et al., 2023 - Google Patents

Malignant Progression of an Ancestral Bone Marrow Clone Harboring a CIC-NUTM2A Fusion in Isolated Myeloid Sarcoma

Kamens et al., 2023

Document ID
18040691525579548347
Author
Kamens J
Dang J
Shaw T
Gout A
Newman S
Hagiwara K
Smith A
Obermayer A
Aldridge S
Ma J
Zhang Y
Wu G
Leventaki V
Santiago T
Raimondi S
Nakitandwe J
Pappo A
Li C
Zhang J
Gruber T
Publication year
Publication venue
Molecular Cancer Research

External Links

Snippet

Myeloid sarcoma is a rare condition consisting of extramedullary myeloid blasts found in association with acute myeloid leukemia or, in the absence of bone marrow involvement. We identified an infant with isolated myeloid sarcoma whose bone marrow was negative for …
Continue reading at aacrjournals.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer

Similar Documents

Publication Publication Date Title
Morel et al. EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer
Liu et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
Cho et al. Cancer-stimulated CAFs enhance monocyte differentiation and protumoral TAM activation via IL6 and GM-CSF secretion
Compagno et al. Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells
Spencer et al. CpG island hypermethylation mediated by DNMT3A is a consequence of AML progression
Zheng et al. Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma
Miyoshi et al. Genomic profiling of large-cell neuroendocrine carcinoma of the lung
Walton et al. CRISPR/Cas9-mediated Trp53 and Brca2 knockout to generate improved murine models of ovarian high-grade serous carcinoma
Chang et al. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling
Schwartzman et al. Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome
Kustikova et al. Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells
Schaettler et al. Characterization of the genomic and immunologic diversity of malignant brain tumors through multisector analysis
Xu et al. G Protein γ subunit 7 loss contributes to progression of clear cell renal cell carcinoma
Bao et al. Molecular subgroups of intrahepatic cholangiocarcinoma discovered by single-cell RNA sequencing–assisted multiomics analysis
Testa et al. Genetic alterations of metastatic colorectal cancer
Bender et al. Refractory and metastatic infantile fibrosarcoma harboring LMNA–NTRK1 fusion shows complete and durable response to crizotinib
Su et al. Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma
Smeenk et al. Selective requirement of MYB for oncogenic hyperactivation of a translocated enhancer in leukemia
Dong et al. Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma
Jiao et al. AID and TET2 co-operation modulates FANCA expression by active demethylation in diffuse large B cell lymphoma
Lazaridou et al. Identification of microRNAs targeting the transporter associated with antigen processing TAP1 in melanoma
Schavgoulidze et al. Multiple myeloma: heterogeneous in every way
Denisova et al. Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies
Flebbe et al. Epigenome mapping identifies tumor-specific gene expression in primary rectal cancer
De Vitis et al. B4GALT1 is a new candidate to maintain the stemness of lung cancer stem cells